Quantifying the Predictive Performance of Objectively Measured Physical Activity on Mortality in the UK Biobank.


Journal

The journals of gerontology. Series A, Biological sciences and medical sciences
ISSN: 1758-535X
Titre abrégé: J Gerontol A Biol Sci Med Sci
Pays: United States
ID NLM: 9502837

Informations de publication

Date de publication:
13 07 2021
Historique:
received: 12 04 2020
pubmed: 2 10 2020
medline: 21 10 2021
entrez: 1 10 2020
Statut: ppublish

Résumé

Objective measures of physical activity (PA) derived from wrist-worn accelerometers are compared with traditional risk factors in terms of mortality prediction performance in the UK Biobank. A subset of participants in the UK Biobank study wore a tri-axial wrist-worn accelerometer in a free-living environment for up to 7 days. A total of 82 304 individuals over the age of 50 (439 707 person-years of follow-up, 1959 deaths) had both accelerometry data that met specified quality criteria and complete data on a set of traditional mortality risk factors. Predictive performance was assessed using cross-validated Concordance (C) for Cox regression models. Forward selection was used to obtain a set of best predictors of mortality. In univariate Cox regression, age was the best predictor of all-cause mortality (C = 0.681) followed by 12 PA predictors, led by minutes of moderate-to-vigorous PA (C = 0.661) and total acceleration (C = 0.661). Overall, 16 of the top 20 predictors were objective PA measures (C = 0.578-0.661). Using a threshold of 0.001 improvement in Concordance, the Concordance for the best model that did not include PA measures was 0.735 (9 covariates) compared with 0.748 (12 covariates) for the best model with PA variables (p-value < .001). Objective measures of PA derived from accelerometry outperform traditional predictors of all-cause mortality in the UK Biobank except age and substantially improve the prediction performance of mortality models based on traditional risk factors. Results confirm and complement previous findings in the National Health and Nutrition Examination Survey (NHANES).

Sections du résumé

BACKGROUND
Objective measures of physical activity (PA) derived from wrist-worn accelerometers are compared with traditional risk factors in terms of mortality prediction performance in the UK Biobank.
METHOD
A subset of participants in the UK Biobank study wore a tri-axial wrist-worn accelerometer in a free-living environment for up to 7 days. A total of 82 304 individuals over the age of 50 (439 707 person-years of follow-up, 1959 deaths) had both accelerometry data that met specified quality criteria and complete data on a set of traditional mortality risk factors. Predictive performance was assessed using cross-validated Concordance (C) for Cox regression models. Forward selection was used to obtain a set of best predictors of mortality.
RESULTS
In univariate Cox regression, age was the best predictor of all-cause mortality (C = 0.681) followed by 12 PA predictors, led by minutes of moderate-to-vigorous PA (C = 0.661) and total acceleration (C = 0.661). Overall, 16 of the top 20 predictors were objective PA measures (C = 0.578-0.661). Using a threshold of 0.001 improvement in Concordance, the Concordance for the best model that did not include PA measures was 0.735 (9 covariates) compared with 0.748 (12 covariates) for the best model with PA variables (p-value < .001).
CONCLUSIONS
Objective measures of PA derived from accelerometry outperform traditional predictors of all-cause mortality in the UK Biobank except age and substantially improve the prediction performance of mortality models based on traditional risk factors. Results confirm and complement previous findings in the National Health and Nutrition Examination Survey (NHANES).

Identifiants

pubmed: 33000171
pii: 5916368
doi: 10.1093/gerona/glaa250
pmc: PMC8277083
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1486-1494

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : T32 AG000247
Pays : United States
Organisme : NIH HHS
ID : R01NS060910
Pays : United States
Organisme : NIA NIH HHS
ID : T32AG000247
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS060910
Pays : United States
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : NCATS NIH HHS
ID : KL2 TR002648
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Références

J Gerontol A Biol Sci Med Sci. 2018 Apr 17;73(5):682-687
pubmed: 28158467
Lancet. 2015 Aug 8;386(9993):533-40
pubmed: 26049253
Am J Audiol. 2015 Dec;24(4):569-72
pubmed: 26650870
Lancet Psychiatry. 2018 Jun;5(6):507-514
pubmed: 29776774
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Am J Epidemiol. 2014 Mar 15;179(6):781-90
pubmed: 24500862
J Am Geriatr Soc. 2010 Feb;58(2):282-91
pubmed: 20374404
Res Q Exerc Sport. 2000 Jun;71 Suppl 2:79-87
pubmed: 25680017
Nature. 2018 Oct;562(7726):210-216
pubmed: 30305740
J Am Geriatr Soc. 2018 May;66(5):886-894
pubmed: 29143320
BMJ. 2020 Feb 12;368:m131
pubmed: 32051121
Res Q Exerc Sport. 2000 Jun;71 Suppl 2:1-14
pubmed: 25680007
Psychosom Med. 2016 Jul-Aug;78(6):686-96
pubmed: 26894325
Biometrics. 2005 Mar;61(1):92-105
pubmed: 15737082
JAMA. 1982 May 14;247(18):2543-6
pubmed: 7069920
PLoS One. 2016 Aug 11;11(8):e0160644
pubmed: 27513333
Am J Clin Nutr. 2016 Nov;104(5):1424-1432
pubmed: 27707702
Prev Med. 2018 Jan;106:233-235
pubmed: 29080825
JAMA Netw Open. 2019 Oct 2;2(10):e1912352
pubmed: 31577355
PLoS One. 2013 Apr 23;8(4):e61691
pubmed: 23626718
J Hypertens. 2016 May;34(5):848-52
pubmed: 26828782
J Pediatr. 2019 Jun;209:190-197.e1
pubmed: 30885646
J Gerontol A Biol Sci Med Sci. 2020 Sep 16;75(9):1779-1785
pubmed: 31504213
PLoS One. 2012;7(6):e37696
pubmed: 22719846
BMC Med. 2019 Jun 12;17(1):108
pubmed: 31186007
Biol Psychiatry. 1996 Aug 15;40(4):259-70
pubmed: 8871772
Stat Biosci. 2019 Jul;11(2):262-287
pubmed: 32047572
Med Sci Sports Exerc. 2014 Sep;46(9):1816-24
pubmed: 24887173
PLoS One. 2017 Feb 1;12(2):e0169649
pubmed: 28146576
Med Sci Sports Exerc. 2016 Jul;48(7):1303-11
pubmed: 26848889
Int J Clin Pract. 2016 Mar;70(3):286-91
pubmed: 26916560

Auteurs

Andrew Leroux (A)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.
Department of Biostatistics & Informatics, Colorado School of Public Health, University of Colorado, Aurora.

Shiyao Xu (S)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Prosenjit Kundu (P)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

John Muschelli (J)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Ekaterina Smirnova (E)

Department of Biostatistics, School of Medicine, Virginia Commonwealth University, Richmond.

Nilanjan Chatterjee (N)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Ciprian Crainiceanu (C)

Department of Biostatistics, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH